Home / World Marketplace / Archive by category Global Health & Biotech (Page 83)

Archive by category Global Health & Biotech

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Jan. 31, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Guggenheim Healthcare Talks 6th Annual Biotechnology Conference: Zymeworks’ management will [...]

Sandoz Launches First and Only Biosimilar for Multiple Sclerosis, Tyruko® (natalizumab), in Germany

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Tyruko® approved for all indications of reference medicine Tyruko® biosimilar to treat adults with highly active relapsing remitting multiple sclerosis (RRMS) Launch strengthens well-established Sandoz biosimilar portfolio in Europe Basel, January 31, 2024 (Korea Bizwire) – [...]

International Barcode of Life Will Change the World

Dr. Paul Hebert receives Benjamin Franklin Medal for revolutionary work Guelph, Ontario, Canada, Jan. 30, 2024 (Korea Bizwire) – Dr. Paul Hebert, the University of Guelph evolutionary biologist who pioneered the field of DNA barcoding, has won the Benjamin Franklin Medal for Earth and Environmental Sciences for 2024. Known as “the father of DNA barcoding,” Hebert [...]

OPEN X Health Launches to Provide Data-driven Creativity to the Pharmaceutical Industry

January 30, 2024, London, UK (Korea Bizwire) – OPEN Health has launched OPEN X Health, a new practice focused on providing data-driven creativity to the pharmaceutical industry. OPEN X Health (OPEN X) launches after two years of investment and growth in the creative communications offering from OPEN Health. OPEN Health acquired ARK, the award-winning London-based healthcare agency, in [...]

KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award

RIYADH, Saudi Arabia, Jan. 29, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSH&RC) in Madinah has won the 2023 Human Experience Guardian of Excellence Award by Press Ganey for its exceptional performance in outpatient services throughout the past year. This prestigious recognition honored a distinguished group of healthcare institutions, from approximately [...]

Philips Delivers Strong Full-year Results; Agrees with FDA on Terms of Consent Decree Focused on Philips Respironics in the US

January 29, 2024 (Korea Bizwire) Delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of first year of 2023-2025 plan Agrees with FDA on terms of consent decree focused on Philips Respironics in the US, providing clarity and a roadmap to demonstrate compliance and to restore the business [...]

KFSH&RC Celebrates 25 Scientists Named in Stanford’s Top 2% Most-Cited Researchers Worldwide

RIYADH, Saudi Arabia, Jan. 24, 2024 (Korea Bizwire) – King Faisal Specialist Hospital and Research Centre honored 25 scientists who joined Stanford University’s prestigious list, marking them among the ‘top 2% most-cited scientists’ list updated in October 2023. The recent release recognizes 25 distinguished KFSH&RC scientists, among the top 2% most-cited researchers worldwide in 2021-2022, [...]

Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (Korea Bizwire) – Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB), a special purpose acquisition company (“Atlantic Coastal”), today announced the filing of [...]

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

London, Jan. 22, 2024 (Korea Bizwire) – January 22, 2024, London, UK – OPEN Health is pleased to announce the appointment of Steven Duryee as Chief Operating and Transformation Officer. In this role, Steve will be responsible for the execution of the strategic plan, large-scale transformation initiatives, driving growth in the US, and evolving OPEN Health’s go-to-market [...]

Sandoz Announces Agreement to Acquire CIMERLI® Business from Coherus, Strengthening Position in US Market

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE CIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®** (ranibizumab-injection) for all approved indications Acquisition strengthens Sandoz ophthalmology portfolio Basel, January 22, 2024 (Korea Bizwire) – Sandoz, the global leader in generic and biosimilar medicines, has signed an agreement to acquire the US [...]